AI Needs A Home: Inside The Workflows That Drive Trials

By Abraham Gutman, Founder and CEO, AG Mednet

The digital landscape of clinical trials is undergoing a fundamental transition. For years, the industry focused on digitizing data and individual tasks, resulting in a complex web of integrated systems like EDC, CTMS, and safety platforms. However, despite these technical connections, the critical decisions that move a trial forward often still rely on informal coordination, email threads, and human memory. This creates an inefficient decision trail that hampers inspections and auditability.

True digital maturity lies in the "execution layer." Rather than simply adding more AI tools or point solutions, organizations must focus on governing the workflows through which decisions travel. By defining who acts and with what context, AI can be embedded as a deliberate collaborator rather than a disconnected accessory. In this model, natural language processing or predictive risk models serve specific roles within a structured journey, ensuring that human judgment and algorithmic insight are captured in a traceable, auditable record. Shifting focus from mere integration to operational orchestration allows sponsors to transform fragmented digital tools into a cohesive engine for trial optimization.